GETI.B

199.05

-0.43%↓

ATT

100.4

-0.99%↓

AMBEA

123.1

-0.08%↓

ARJOB

26.8

-0.74%↓

MSON.B

11.65

0%↓

GETI.B

199.05

-0.43%↓

ATT

100.4

-0.99%↓

AMBEA

123.1

-0.08%↓

ARJOB

26.8

-0.74%↓

MSON.B

11.65

0%↓

GETI.B

199.05

-0.43%↓

ATT

100.4

-0.99%↓

AMBEA

123.1

-0.08%↓

ARJOB

26.8

-0.74%↓

MSON.B

11.65

0%↓

GETI.B

199.05

-0.43%↓

ATT

100.4

-0.99%↓

AMBEA

123.1

-0.08%↓

ARJOB

26.8

-0.74%↓

MSON.B

11.65

0%↓

GETI.B

199.05

-0.43%↓

ATT

100.4

-0.99%↓

AMBEA

123.1

-0.08%↓

ARJOB

26.8

-0.74%↓

MSON.B

11.65

0%↓

Home・Список акций・Vivesto AB

Vivesto AB

Открыт

Купить Продать

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

Макс.

Ключевые показатели
By Trading Economics
Доход	2.3M -7.2M
Прибыль на акцию	-0.013
Сотрудники	4
EBITDA	-7.1M

Дивиденды
By Dow Jones
Следующий отчет о доходах	27 февр. 2026 г.

Рыночная статистика
By TradingEconomics
Рыночная капитализация	-27M 51M
Предыдущая цена открытия	0
Предыдущая цена закрытия	0

Vivesto AB График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

24 февр. 2026 г., 23:07 UTC

Отчет

Woolworths 1st Half Profit Hit By Worker Pay Dispute, Still Boosts Dividend

24 февр. 2026 г., 23:01 UTC

Отчет

Fortescue 1st Half Net Profit, Dividend Rise on Higher Shipments, Prices -- Update

24 февр. 2026 г., 22:59 UTC

Отчет

WiseTech to Cut 2,000 Jobs as It Asks AI to Boost Profitability -- Update

24 февр. 2026 г., 22:42 UTC

Отчет

WiseTech to Cut 2,000 Jobs as It Asks AI to Boost Profitability

24 февр. 2026 г., 22:24 UTC

Приобретения, слияния, поглощения

Warner Bros. Discovery Board Says Paramount Skydance's New Proposal Could Top Netflix Agreement -- Update

24 февр. 2026 г., 23:46 UTC

Обсуждения рынка

Gold Edges Higher Amid Possible Position Adjustments -- Market Talk

24 февр. 2026 г., 23:36 UTC

Обсуждения рынка

Nikkei May Rise, Tracking Wall Street's Rebound -- Market Talk

24 февр. 2026 г., 23:30 UTC

Обсуждения рынка

Fortescue's Copper Bet Is Long Term, While Iron Ore Remains Near-Term Driver -- Market Talk

24 февр. 2026 г., 23:20 UTC

Обсуждения рынка

Fortescue Dividend Beat Overshadows Profit Miss -- Market Talk

24 февр. 2026 г., 23:20 UTC

Обсуждения рынка

Global Equities Roundup: Market Talk

24 февр. 2026 г., 23:16 UTC

Отчет

Oversea-Chinese Banking Corp.'s CEO: "Looking Ahead, We Remain Cautious Yet Positive">O39.SG

24 февр. 2026 г., 23:13 UTC

Отчет

Oversea-Chinese Banking Corp. FY25 Non-Interest Income S$5.46B Vs. S$4.72B >O39.SG

24 февр. 2026 г., 23:12 UTC

Отчет

Oversea-Chinese Banking Corp.: FY25 Net Interest Income S$9.15B Vs. S$9.76B>O39.SG

24 февр. 2026 г., 23:10 UTC

Отчет

Oversea-Chinese Banking Corp. FY25 NPL Ratio 0.9%, Unchanged on Year>O39.SG

24 февр. 2026 г., 23:10 UTC

Отчет

Oversea-Chinese Banking Corp. FY25 Net Interest Margin 1.91%, Down 29bps on Year>O39.SG

24 февр. 2026 г., 23:08 UTC

Отчет

Oversea-Chinese Banking Corp. FY25 Net S$7.42B Vs. Net S$7.59B >O39.SG

24 февр. 2026 г., 23:07 UTC

Отчет

Oversea-Chinese Banking Corp. FY25 Total Income S$14.61B Vs. S$14.47B>O39.SG

24 февр. 2026 г., 22:52 UTC

Отчет

Woolworths 1H Profit Hit By Worker Pay Dispute, Still Boosts Dividend

24 февр. 2026 г., 22:46 UTC

Отчет

Fortescue 1H Net Profit, Dividend Rise on Higher Shipments, Prices -- Update

24 февр. 2026 г., 22:31 UTC

Приобретения, слияния, поглощения

Warner Receives New Bid From Paramount -- 3rd Update

24 февр. 2026 г., 22:29 UTC

Отчет

Woolworths: FY Ebit Growth for Australian Food Expected at Upper End of Mid-to-High Single Digit Range Provided in August

24 февр. 2026 г., 22:28 UTC

Отчет

Woolworths: Australian Food Current Growth Rates Reflect Some Benefit from Cycling of Industrial Action Impacts

24 февр. 2026 г., 22:27 UTC

Отчет

Woolworths: Australian Food Sales +7.2% Excluding Tobacco in 2H First Seven Weeks

24 февр. 2026 г., 22:27 UTC

Отчет

Woolworths: Australian Food Sales +5.8% in 2H First Seven Weeks

24 февр. 2026 г., 22:25 UTC

Отчет

Woolworths: Customers Continue to be Value-Focused, Shopping Multiple Retailers in Highly Competitive Environment

24 февр. 2026 г., 22:24 UTC

Отчет

Woolworths: Trading in 3Q to Date Has Been Strong in Australian Food

24 февр. 2026 г., 22:23 UTC

Отчет

Woolworths 1H Group Sales A$37.1 Bln, Up 3.4%

24 февр. 2026 г., 22:22 UTC

Отчет

Woolworths Interim Dividend 45 Australian Cents/Share

24 февр. 2026 г., 22:22 UTC

Отчет

Woolworths 1H Profit Before Significant Items A$859 Mln, Up 16.4%

24 февр. 2026 г., 22:21 UTC

Отчет

Woolworths 1H Statutory Net Profit A$374 Mln, Down 49.4%

Сравнение c конкурентами

Изменение цены

Vivesto AB Прогноз

Финансовые показатели

Расходы на продажи и администрирование

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

О компании Vivesto AB

Vivesto AB develops, produces, markets, and sells drugs in the field of human and veterinary oncology in Sweden. Its lead product is Apealea (paclitaxel micellar) for the treatment of ovarian cancer. The company's products portfolio includes Docetaxel micellar, a patented formulation that combines cytotoxin docetaxel with XR-17, which is in Phase 1b clinical trial for the treatment of prostate cancer; and Cantrixil to treat ovarian cancer. its animal health product portfolio includes Paccal Vet, a formulation of paclitaxel with its XR-17 encapsulation technology for the treatment of canine mastocytoma; and Doxophos Vet, a patented formulation of doxorubicin to treat lymphoma. The company was formerly known as Oasmia Pharmaceutical AB (publ) and changed its name to Vivesto AB in March 2022. Vivesto AB was incorporated in 1988 and is headquartered in Solna, Sweden.